Erysense, a Lab-on-a-Chip-Based Point-of-Care Device to Evaluate Red Blood Cell Flow Properties With Multiple Clinical Applications
In many medical disciplines, red blood cells are discovered to be biomarkers since they “experience” various conditions in basically all organs of the body. Classical examples are diabetes and hypercholesterolemia. However, recently the red blood cell distribution width (RDW), is often referred to,...
Main Authors: | Steffen M. Recktenwald, Marcelle G. M. Lopes, Stephana Peter, Sebastian Hof, Greta Simionato, Kevin Peikert, Andreas Hermann, Adrian Danek, Kai van Bentum, Hermann Eichler, Christian Wagner, Stephan Quint, Lars Kaestner |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2022.884690/full |
Similar Items
-
Commentary: Acanthocytes identified in Huntington's disease
by: Kevin Peikert, et al.
Published: (2022-11-01) -
Acanthocyte Sedimentation Rate as a Diagnostic Biomarker for Neuroacanthocytosis Syndromes: Experimental Evidence and Physical Justification
by: Alexis Darras, et al.
Published: (2021-04-01) -
Proceedings of the Ninth International Meeting on Neuroacanthocytosis Syndromes
by: Kevin Peikert, et al.
Published: (2018-07-01) -
The Erythrocyte Sedimentation Rate and Its Relation to Cell Shape and Rigidity of Red Blood Cells from Chorea-Acanthocytosis Patients in an Off-Label Treatment with Dasatinib
by: Antonia Rabe, et al.
Published: (2021-05-01) -
Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19
by: Steffen M Recktenwald, et al.
Published: (2022-12-01)